Technology

Pulse Biosciences

$26.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$2.08 (+8.37%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell PLSE and other stocks, options, and ETFs commission-free!

About PLSE

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA. The listed name for PLSE is Pulse Biosciences, Inc Common Stock (DE).

CEO
Darrin R. Uecker
Employees
82
Headquarters
Hayward, California
Founded
2014
Market Cap
691.76M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
167.47K
High Today
$28.86
Low Today
$24.66
Open Price
$24.66
Volume
185.35K
52 Week High
$28.86
52 Week Low
$5.11

Collections

PLSE Earnings

-$0.66
-$0.44
-$0.22
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, After Hours

You May Also Like

KMB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure